These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8576841)

  • 1. Oral absorption of CGS-20625, an insoluble drug, in dogs and man.
    Hirschberg Y; Oberle RL; Ortiz M; Lau H; Markowska M
    J Pharmacokinet Biopharm; 1995 Feb; 23(1):11-23. PubMed ID: 8576841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different absorption profiles of deramciclane in man and in dog.
    Kanerva H; Klebovich I; Drabant S; Urtti A; Nevalainen T
    J Pharm Pharmacol; 1998 Oct; 50(10):1087-93. PubMed ID: 9821653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability assessment of oral coenzyme Q10 formulations in dogs.
    Zaghloul AA; Gurley B; Khan M; Bhagavan H; Chopra R; Reddy I
    Drug Dev Ind Pharm; 2002 Nov; 28(10):1195-200. PubMed ID: 12476865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture.
    Joshi HN; Tejwani RW; Davidovich M; Sahasrabudhe VP; Jemal M; Bathala MS; Varia SA; Serajuddin AT
    Int J Pharm; 2004 Jan; 269(1):251-8. PubMed ID: 14698596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine.
    Yuen GJ; Morris DM; Mydlow PK; Haidar S; Hall ST; Hussey EK
    J Clin Pharmacol; 1995 Dec; 35(12):1174-80. PubMed ID: 8750368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
    Wu Y; Loper A; Landis E; Hettrick L; Novak L; Lynn K; Chen C; Thompson K; Higgins R; Batra U; Shelukar S; Kwei G; Storey D
    Int J Pharm; 2004 Nov; 285(1-2):135-46. PubMed ID: 15488686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological disposition of CGS 16617 in rat, dog, and man.
    Egger H; Kochak G; Robertson P; Iannucci R; Rufino FA; Stancato F
    Drug Metab Dispos; 1989; 17(6):669-72. PubMed ID: 2575505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved oral absorption of L-365,260, a poorly soluble drug.
    Lin JH; Storey DE; Chen IW; Xu X
    Biopharm Drug Dispos; 1996 Jan; 17(1):1-15. PubMed ID: 8991487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides.
    He YL; Murby S; Warhurst G; Gifford L; Walker D; Ayrton J; Eastmond R; Rowland M
    J Pharm Sci; 1998 May; 87(5):626-33. PubMed ID: 9572915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of dissolution and oral absorption of ER-34122, a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion.
    Kushida I; Ichikawa M; Asakawa N
    J Pharm Sci; 2002 Jan; 91(1):258-66. PubMed ID: 11782915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
    Guzmán HR; Tawa M; Zhang Z; Ratanabanangkoon P; Shaw P; Gardner CR; Chen H; Moreau JP; Almarsson O; Remenar JF
    J Pharm Sci; 2007 Oct; 96(10):2686-702. PubMed ID: 17518357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and relative bioavailability of probucol inclusion complex capsule in healthy dogs].
    Zhang Z; Chen BL; Wang K; Huang YL; Fang SQ; Gu DL; Fang L; Han SJ
    Yao Xue Xue Bao; 2002 Mar; 37(3):210-3. PubMed ID: 12579765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J; Smith RP; Ferguson RA
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption.
    Paulson SK; Vaughn MB; Jessen SM; Lawal Y; Gresk CJ; Yan B; Maziasz TJ; Cook CS; Karim A
    J Pharmacol Exp Ther; 2001 May; 297(2):638-45. PubMed ID: 11303053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of food on the bioavailability of SDZ DJN 608, an oral hypoglycemic agent, from a tablet and a liquid-filled capsule in the dog.
    Tse FL; Labbadia D; Habucky K; Karara A; Au S
    Pharm Res; 1996 Mar; 13(3):440-4. PubMed ID: 8692738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.
    Van den Bergh A; Van Hemelryck S; Bevernage J; Van Peer A; Brewster M; Mackie C; Mannaert E
    Mol Pharm; 2018 Jul; 15(7):2633-2645. PubMed ID: 29799758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and Pharmacokinetics of TRPV1 Antagonist Mavatrep (JNJ-39439335) Tablet and Capsule Formulations in Healthy Men: Two Open-Label, Crossover, Single-Dose Phase 1 Studies.
    Manitpisitkul P; Shalayda K; Russell L; Sanga P; Williams Y; Solanki B; Caruso J; Moyer JA
    Clin Pharmacol Drug Dev; 2018 Sep; 7(7):699-711. PubMed ID: 29125700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.